About us

NeoDynamics is a Swedish medical technology company based on research conducted at the renowned Karolinska Institutet. Our aim is to drive progress within precision cancer management with minimally invasive technologies that improve precision, quality and safety in tissue sampling.


Certificate delivered by the European Commission, as part of Horizon 2020, the EU Framework Programme for Research and  Innovation 2014-2020



Recipient of multiple
VINNOVA grants

2012, 2013, 2017


Nominated for
Framtidens Entrepenör /
Entrepreneur of the future


Anna Eriksrud, CEO, NeoDynamics:

“Our innovative medical solutions are designed to help physicians better diagnose and treat cancer, thereby enhancing patient care and saving lives.”